Show me excellent biomedical stock to own

Based on your interest in biomedical stocks, we should focus on those with the following characteristics: 1. **Strong Earnings Growth** - 3-Year EPS CAGR > 10% 2. **Positive Cash Flow Growth** - 3-Year Operating Cash Flow CAGR > 0 3. **Low Leverage** - Debt-to-Equity Ratio < 0.5 However, no results were found that meet all these criteria. Consider adjusting your criteria to refine your search. Alternatively, you may want to explore the following highly regarded biomedical stocks: 1. **Vertex Pharmaceuticals Inc. (VRTX)**: - Implied upside: 12.2% - Recent FDA approval of exa-cel therapy 2. **Regeneron Pharmaceuticals Inc. (REGN)**: - Implied upside: 9.9% - Strong pipeline and recent FDA approval 3. **Iqvia Holdings Inc. (IQV)**: - Implied upside: 16.0% - Leading position in biotech industry These stocks demonstrate solid growth potential and are actively contributing to the biotech industry. Vertex Pharmaceuticals, with its cystic fibrosis treatment and gene-editing therapy, Regeneron Pharmaceuticals with its diverse therapeutic focus, and Iqvia Holdings, a leading biotech company, are all worthy of consideration.